“They're using de-identified patient data, we're going to be tracking to see whether doing these whole body MRIs actually improve health outcomes down the line”
♫
Said on The Readout Loud
Ned Potts · Business Of Biotech · Translating A New Discovery Into A Novel Cancer Therapy With Grid Therapeutics' Ned Patz, M.D.
Audio streams from the publisher’s own feed. Verbatim does not host or copy it.
used immunoblot screening of patient serum proteins to identify autoantibodies present in early-stage non-metastatic lung cancer patients
“They're using de-identified patient data, we're going to be tracking to see whether doing these whole body MRIs actually improve health outcomes down the line”
“I’d say a patient base of at least 3,000, right? ... the higher the patient base number, the more the patients are coming to the office for the systems and less to the personality of the doctor.”
“We start asking to screen our patients in perimenopause… stimulus is movement, especially resistance training”
“We have 2 million patients on an annual basis that are relying on us for their primary care.”
The strongest new moments on your topics, in the speakers' own words. Free for three topics.
No card. No password. One-click unsubscribe.
Pro watches up to 25 names or phrases and emails you the morning after they are said.
See Pro, $29 a monthVerbatim quotes a short extract and links to the episode; the episode belongs to its publisher. Remove a show.